$PWOD
PENNS WOODS BANCORP INC Stock $pwod

$pwod Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000071660520000034 Filed on November 09, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$15.05M	$15.39M	$17.08M
YoY Change	-8.34%	-9.93%	12.41%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$830.0K	$1.070M	$580.0K
YoY Change	-25.23%	84.48%	-21.62%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$3.079M	$3.542M	$4.181M
YoY Change	-24.79%	-15.28%	42.07%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$4.817M	$5.528M	$5.824M
YoY Change	48.95%	-5.08%	24.36%
Income Tax	$911.0K	$1.051M	$1.170M
% Of Pretax Income	18.91%	19.01%	20.09%
Net Earnings	$3.906M	$4.472M	$4.650M
YoY Change	37.68%	-3.83%	21.54%
Net Earnings / Revenue	25.96%	29.06%	27.22%
Basic Earnings Per Share	$0.56	$0.63	$0.66
Diluted Earnings Per Share	$0.56	$0.63	$0.65
COMMON SHARES
Basic Shares Outstanding	7.052M shares	7.045M shares	7.037M shares
Diluted Shares Outstanding		7.045M shares	7.037M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$213.4M	$226.3M	$57.34M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$32.70M	$32.89M	$33.37M
YoY Change	-0.69%	-1.44%	21.95%
Goodwill	$17.10M	$17.10M	$17.10M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$671.0K	$724.0K	$960.0K
YoY Change	-25.28%	-24.58%	-22.14%
Long-Term Investments
YoY Change
Other Assets	$2.500M	$3.400M	$3.700M
YoY Change	-24.24%	-8.11%	-30.19%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.835B	$1.841B	$1.673B
YoY Change	10.17%	10.02%	0.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.100M	$1.500M	$1.700M
YoY Change	-35.29%	-11.76%	54.55%
Accrued Expenses	$3.200M	$3.200M	$4.200M
YoY Change	-23.81%	-23.81%
Deferred Revenue
YoY Change
Short-Term Debt	$5.244M	$15.01M	$5.987M
YoY Change	6.59%	150.69%	-96.36%
Long-Term Debt Due	$300.0K	$5.500M
YoY Change
Total Short-Term Liabilities	$4.600M	$10.20M	$5.900M
YoY Change	-22.03%	72.88%	436.36%
LONG-TERM LIABILITIES
Long-Term Debt	$5.200M	$0.00	$6.000M
YoY Change	-7.14%	-100.0%	-95.68%
Other Long-Term Liabilities	$13.00M	$13.30M	$11.50M
YoY Change	-5.11%	15.65%	-22.3%
Total Long-Term Liabilities	$18.20M	$13.30M	$17.50M
YoY Change	-5.7%	-24.0%	-88.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.600M	$10.20M	$5.900M
Total Long-Term Liabilities	$18.20M	$13.30M	$17.50M
Total Liabilities	$1.670B	$1.678B	$1.518B
YoY Change	10.6%	10.56%	-0.77%
SHAREHOLDERS EQUITY
Retained Earnings	$82.77M	$81.13M	$76.01M
YoY Change	8.08%	6.73%	12.1%
Common Stock	$41.85M	$41.82M	$41.76M
YoY Change	0.16%	0.15%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$12.12M	$12.12M	$12.12M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	480.2K shares	480.2K shares	480.2K shares
Shareholders Equity	$164.1M	$162.4M	$155.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.835B	$1.841B	$1.673B
YoY Change	10.17%	10.02%	0.16%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	$3.906M	$4.472M	$4.650M
YoY Change	37.68%	-3.83%	21.54%
Depreciation, Depletion And Amortization	$830.0K	$1.070M	$580.0K
YoY Change	-25.23%	84.48%	-21.62%
Cash From Operating Activities	$7.100M	$2.910M	$7.390M
YoY Change	-512.79%	-60.62%	180.99%
INVESTING ACTIVITIES
Capital Expenditures	$160.0K	-$540.0K	-$480.0K
YoY Change	-117.58%	12.5%	14.29%
Acquisitions
YoY Change
Other Investing Activities	-$10.79M	$11.85M	$13.53M
YoY Change	-281.04%	-12.42%	-128.21%
Cash From Investing Activities	-$10.63M	$11.31M	$13.06M
YoY Change	-310.5%	-13.4%	-126.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.380M	-3.130M	-42.64M
YoY Change	-22.35%	-92.66%	-168.66%
NET CHANGE
Cash From Operating Activities	7.100M	2.910M	7.390M
Cash From Investing Activities	-10.63M	11.31M	13.06M
Cash From Financing Activities	-9.380M	-3.130M	-42.64M
Net Change In Cash	-12.91M	11.09M	-22.19M
YoY Change	47.54%	-149.98%	-235.8%
FREE CASH FLOW
Cash From Operating Activities	$7.100M	$2.910M	$7.390M
Capital Expenditures	$160.0K	-$540.0K	-$480.0K
Free Cash Flow	$6.940M	$3.450M	$7.870M
YoY Change	-956.79%	-56.16%	158.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000716605
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-17077
	dei	Entity Registrant Name EntityRegistrantName	PENNS WOODS BANCORP INC
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Market Street, P.O. Box 967
CY2020Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	191285000	USD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-2226454
	dei	Entity Address City Or Town EntityAddressCityOrTown	Williamsport
	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	17703-0967
	dei	City Area Code CityAreaCode	570
	dei	Local Phone Number LocalPhoneNumber	322-1111
	dei	Security12b Title Security12bTitle	Common stock, $5.55 par value
	dei	Trading Symbol TradingSymbol	PWOD
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7051783	shares
CY2020Q3	us-gaap	Cash And Due From Banks CashAndDueFromBanks	34987000	USD
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	24725000	USD
CY2019Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	23864000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	226272000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48589000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	149675000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	148619000	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1291000	USD
CY2019Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1261000	USD
CY2020Q3	us-gaap	Trading Securities Debt TradingSecuritiesDebt	35000	USD
CY2019Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	51000	USD
CY2020Q3	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	15006000	USD
CY2019Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	13528000	USD
CY2020Q3	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	6647000	USD
CY2019Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	4232000	USD
CY2020Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	1349140000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1355544000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13429000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3184000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11894000	USD
CY2020Q3	us-gaap	Notes Receivable Net NotesReceivableNet	1335711000	USD
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1343650000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32886000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32929000	USD
CY2020Q3	us-gaap	Interest Receivable InterestReceivable	8540000	USD
CY2019Q4	us-gaap	Interest Receivable InterestReceivable	5246000	USD
CY2020Q3	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	33474000	USD
CY2019Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	29253000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	17104000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	17104000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	724000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	898000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4154000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3409000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3338000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	6821000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	12471000	USD
CY2020Q3	us-gaap	Assets Assets	1840779000	USD
CY2019Q4	us-gaap	Assets Assets	1665323000	USD
CY2020Q3	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1057562000	USD
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	989259000	USD
CY2020Q3	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	434248000	USD
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	334746000	USD
CY2020Q3	us-gaap	Deposits Domestic DepositsDomestic	1491810000	USD
CY2019Q4	us-gaap	Deposits Domestic DepositsDomestic	1324005000	USD
CY2020Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	15009000	USD
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	4920000	USD
CY2020Q3	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	153534000	USD
CY2019Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	161920000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1491000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1671000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3219000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4170000	USD
CY2020Q3	us-gaap	Other Liabilities OtherLiabilities	13287000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	13655000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	1678350000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1510341000	USD
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	5.55
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	5.55
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	22500000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	22500000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7527605	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7520740	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7047380	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7040515	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	41820000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	41782000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52268000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51487000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	81127000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	76583000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4440000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	2455000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	5118000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	5232000	USD
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	480225	shares
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	480225	shares
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	12115000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	12115000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	162422000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	154960000	USD
CY2020Q3	us-gaap	Minority Interest MinorityInterest	7000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	22000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	162429000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154982000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1840779000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1665323000	USD
CY2020Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	14080000	USD
CY2019Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	15426000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	43403000	USD
CY2020Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	212000	USD
CY2019Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	493000	USD
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	747000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	45595000	USD
CY2020Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	925000	USD
CY2019Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	998000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2958000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2899000	USD
CY2020Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	170000	USD
CY2019Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	167000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	484000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	520000	USD
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1345000	USD
CY2020Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	15387000	USD
CY2019Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	17084000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	47592000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	50359000	USD
CY2020Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2569000	USD
CY2019Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3165000	USD
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	8406000	USD
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	8336000	USD
CY2020Q3	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	8000	USD
CY2019Q3	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	7000	USD
	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	37000	USD
	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	790000	USD
CY2020Q3	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	965000	USD
CY2019Q3	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	1009000	USD
	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	2893000	USD
	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	2739000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	3542000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	4181000	USD
	us-gaap	Interest Expense InterestExpense	11336000	USD
	us-gaap	Interest Expense InterestExpense	11865000	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11845000	USD
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12903000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	36256000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	38494000	USD
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	645000	USD
CY2019Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	360000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	2040000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1035000	USD
CY2020Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11200000	USD
CY2019Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	12543000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	34216000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	37459000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	1013000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	189000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	1220000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	200000	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	USD
CY2019Q3	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-21000	USD
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	30000	USD
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	44000	USD
CY2020Q3	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-2000	USD
CY2019Q3	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	2000	USD
	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-16000	USD
	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	15000	USD
CY2020Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	156000	USD
CY2019Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	143000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	492000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	434000	USD
CY2020Q3	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	1449000	USD
CY2019Q3	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	583000	USD
	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	2921000	USD
	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	1246000	USD
CY2020Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	354000	USD
CY2019Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	525000	USD
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1162000	USD
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1420000	USD
CY2020Q3	us-gaap	Noninterest Income NoninterestIncome	4035000	USD
CY2019Q3	us-gaap	Noninterest Income NoninterestIncome	2822000	USD
	us-gaap	Noninterest Income NoninterestIncome	9093000	USD
	us-gaap	Noninterest Income NoninterestIncome	7545000	USD
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5465000	USD
CY2019Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5488000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	16362000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	16512000	USD
CY2020Q3	us-gaap	Occupancy Net OccupancyNet	599000	USD
CY2019Q3	us-gaap	Occupancy Net OccupancyNet	638000	USD
	us-gaap	Occupancy Net OccupancyNet	1927000	USD
	us-gaap	Occupancy Net OccupancyNet	2085000	USD
CY2020Q3	us-gaap	Equipment Expense EquipmentExpense	837000	USD
CY2019Q3	us-gaap	Equipment Expense EquipmentExpense	885000	USD
	us-gaap	Equipment Expense EquipmentExpense	2525000	USD
	us-gaap	Equipment Expense EquipmentExpense	2421000	USD
CY2020Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	257000	USD
CY2019Q3	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	234000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	743000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	629000	USD
CY2020Q3	pwod	Share Tax Expense ShareTaxExpense	340000	USD
CY2019Q3	pwod	Share Tax Expense ShareTaxExpense	285000	USD
	pwod	Share Tax Expense ShareTaxExpense	948000	USD
	pwod	Share Tax Expense ShareTaxExpense	863000	USD
CY2020Q3	pwod	Amortization Of Investment In Low Income Housing Limited Partnerships AmortizationOfInvestmentInLowIncomeHousingLimitedPartnerships	608000	USD
CY2019Q3	pwod	Amortization Of Investment In Low Income Housing Limited Partnerships AmortizationOfInvestmentInLowIncomeHousingLimitedPartnerships	585000	USD
	pwod	Amortization Of Investment In Low Income Housing Limited Partnerships AmortizationOfInvestmentInLowIncomeHousingLimitedPartnerships	1888000	USD
	pwod	Amortization Of Investment In Low Income Housing Limited Partnerships AmortizationOfInvestmentInLowIncomeHousingLimitedPartnerships	1834000	USD
CY2020Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	271000	USD
CY2019Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	0	USD
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	650000	USD
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	504000	USD
CY2020Q3	us-gaap	Marketing Expense MarketingExpense	61000	USD
CY2019Q3	us-gaap	Marketing Expense MarketingExpense	98000	USD
	us-gaap	Marketing Expense MarketingExpense	170000	USD
	us-gaap	Marketing Expense MarketingExpense	233000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202000	USD
CY2020Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1216000	USD
CY2019Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1266000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	4041000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	4131000	USD
CY2020Q3	us-gaap	Noninterest Expense NoninterestExpense	9707000	USD
CY2019Q3	us-gaap	Noninterest Expense NoninterestExpense	9541000	USD
	us-gaap	Noninterest Expense NoninterestExpense	29428000	USD
	us-gaap	Noninterest Expense NoninterestExpense	29414000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5528000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5824000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13881000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15590000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1051000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1170000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2563000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2741000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	4477000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	4654000	USD
	us-gaap	Profit Loss ProfitLoss	11318000	USD
	us-gaap	Profit Loss ProfitLoss	12849000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	13000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	4472000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	4650000	USD
	us-gaap	Net Income Loss NetIncomeLoss	11305000	USD
	us-gaap	Net Income Loss NetIncomeLoss	12839000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.82
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.82
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7045336	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7037055	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7042578	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7036181	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7045336	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7037055	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7042578	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7036181	shares
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.31
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.94
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	4472000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	4650000	USD
	us-gaap	Net Income Loss NetIncomeLoss	11305000	USD
	us-gaap	Net Income Loss NetIncomeLoss	12839000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1324000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1261000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	3733000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	6056000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	278000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	265000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	784000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	1272000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1013000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	189000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1220000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	200000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	213000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	40000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	256000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	42000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-52000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-46000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-144000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-140000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-11000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-9000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-30000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-29000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	287000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	884000	USD
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2099000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4737000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4759000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5534000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13404000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17576000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	159608000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	4477000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	287000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	239000	USD
CY2020Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2255000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	21000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	USD
CY2020Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	28000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	162429000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	151521000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	4654000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	884000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	185000	USD
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.31
CY2019Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2206000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	42000	USD
CY2019Q3	pwod	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits	-19000	USD
CY2019Q3	pwod	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits	-19000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	155061000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154982000	USD
	us-gaap	Profit Loss ProfitLoss	11318000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2099000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	675000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	6761000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	64000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	28000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	162429000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	143544000	USD
	us-gaap	Profit Loss ProfitLoss	12849000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4737000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	498000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.94
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	6617000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	69000	USD
	pwod	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits	-19000	USD
	pwod	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits	-19000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	155061000	USD
	us-gaap	Profit Loss ProfitLoss	11318000	USD
	us-gaap	Profit Loss ProfitLoss	12849000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	2310000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1904000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	14000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	2040000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1035000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	675000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	498000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-382000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-499000	USD
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	1220000	USD
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	200000	USD
	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	95661000	USD
	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	41601000	USD
	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	96167000	USD
	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	43908000	USD
	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	2921000	USD
	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	1246000	USD
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	30000	USD
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	44000	USD
	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-16000	USD
	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	15000	USD
	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	0	USD
	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	78000	USD
	pwod	Purchaseof Trading Securities PurchaseofTradingSecurities	0	USD
	pwod	Purchaseof Trading Securities PurchaseofTradingSecurities	74000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	492000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	434000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	599000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-180000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-2756000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1766000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14901000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15773000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	37252000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	16289000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	567000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3089000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	35524000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	28611000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-5692000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-18625000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2830000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1798000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	336000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	226000	USD
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	502000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	3970000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	30000	USD
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	248000	USD
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	628000	USD
	us-gaap	Payments To Acquire Limited Partnership Interests PaymentsToAcquireLimitedPartnershipInterests	0	USD
	pwod	Proceeds From Redemption Of Regulatory Stock ProceedsFromRedemptionOfRegulatoryStock	2881000	USD
	pwod	Proceeds From Redemption Of Regulatory Stock ProceedsFromRedemptionOfRegulatoryStock	13659000	USD
	pwod	Purchases Of Regulatory Stock PurchasesOfRegulatoryStock	4359000	USD
	pwod	Purchases Of Regulatory Stock PurchasesOfRegulatoryStock	8299000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-109000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13426000	USD
	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	68303000	USD
	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	105989000	USD
	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	99502000	USD
	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	6515000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	35000000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	50000000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	43333000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	32608000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	10089000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	-161878000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	53000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	70000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	6761000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	6617000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	144000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	69000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	162891000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-38600000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	177683000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9401000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48589000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66742000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	226272000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57341000	USD
	us-gaap	Interest Paid Net InterestPaidNet	11516000	USD
	us-gaap	Interest Paid Net InterestPaidNet	11349000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2375000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3125000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6026000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4298000	USD
	pwod	Transfer From Loans To Foreclosed Assets TransferFromLoansToForeclosedAssets	207000	USD
	pwod	Transfer From Loans To Foreclosed Assets TransferFromLoansToForeclosedAssets	525000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	1046000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	996000	USD
CY2020Q3	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	759000	USD
CY2019Q3	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	112000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	287000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	884000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	2949000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	4784000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	850000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	47000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2099000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4737000	USD
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	Recent Accounting Pronouncements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be effected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. With certain exceptions, transition to the new requirements will be through a cumulative-effect adjustment to opening retained earnings as of the beginning of the first reporting period in which the guidance is adopted. In November 2019, the FASB issued ASU 2019-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We expect to recognize a one-time cumulative-effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2017, the FASB issued ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in this Update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In November 2019, the FASB issued ASU 2019-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which deferred the effective date for ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Intangibles – Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for smaller reporting companies to fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2018, the FASB issued ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Compensation – Retirement Benefits (Topic 715-20).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> This Update amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The Update eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The Update also removes the disclosure requirements for the effects of a one percentage point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. This Update is effective for public business entities for fiscal years ending after December 15, 2020, and must be applied on a retrospective basis. For all other entities, this Update is effective for fiscal years ending after December 15, 2021. This Update is not expected to have a significant impact on the Company’s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In April 2019, the FASB issued ASU 2019-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">which affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">, Financial Instruments – Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, amendments are effective for SEC registrants for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. For all other public business entities, the effective date is for fiscal years beginning after December 15, 2020, and for all other entities, the effective date is for fiscal years beginning after December 15, 2021. Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">amendments are effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods beginning after December 15, 2020. For entities that have adopted the amendments in Update 2017-12, the effective date is as of the beginning of the first annual period beginning after the issuance of this Update. Topic 825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">, Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">amendments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years. In November 2019, the FASB issued ASU 2019-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Furthermore, the ASU provides a one-year deferral of the effective dates of the ASUs on derivatives and hedging for companies that are not public business entities. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In May 2019, the FASB issued ASU 2019-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments – Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which allows entities to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost upon adoption of the new credit losses standard. To be eligible for the transition election, the existing financial asset must otherwise be both within the scope of the new credit losses standard and eligible for applying the fair value option in ASC 825-10.3. The election must be applied on an instrument-by-instrument basis and is not available for either available-for-sale or held-to-maturity debt securities. For entities that elect the fair value option, the difference between the carrying amount and the fair value of the financial asset would be recognized through a cumulative-effect adjustment to opening retained earnings as of the date an entity adopted ASU 2016-13. Changes in fair value of that financial asset would subsequently be reported in current earnings. For entities that have not yet adopted ASU 2016-13, the effective dates and transition requirements are the same as those in ASU 2016-13. For entities that have adopted ASU 2016-13, ASU 2019-05 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted once ASU 2016-13 has been adopted. In November 2019, the FASB issued ASU 2019-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt ASU 2016-13. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2019, the FASB issued ASU 2019-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Services ‒ Insurance (Topic 944)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which defers the effective date of the amendments in Update 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Services ‒ Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. For public business entities that meet the definition of an SEC filer, excluding entities eligible to be smaller reporting companies, as defined by the SEC, the amendments in Update 2018-12 are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early application of the amendments in Update 2018-12 is permitted. For all other entities, the amendments in Update 2018-12 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early application of the amendments in Update 2018-12 is permitted. This Update is not expected to have a significant impact on the Company’s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2019, the FASB issued ASU 2019-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Update defers the effective dates of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This Update also amends the mandatory effective date for the elimination of Step 2 from the goodwill impairment test under ASU No. 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Intangibles ‒ Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (Goodwill)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to align with those used for credit losses. Furthermore, the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ASU provides a one-year deferral of the effective dates of the ASUs on derivatives and hedging and leases for companies that are not public business entities. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2019, the FASB issued ASU 2019-11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements to Topic 326, Financial Instruments – Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to clarify its new credit impairment guidance in ASC 326, based on implementation issues raised by stakeholders. This Update clarified, among other things, that expected recoveries are to be included in the allowance for credit losses for these financial assets; an accounting policy election can be made to adjust the effective interest rate for existing troubled debt restructurings based on the prepayment assumptions instead of the prepayment assumptions applicable immediately prior to the restructuring event; and extends the practical expedient to exclude accrued interest receivable from all additional relevant disclosures involving amortized cost basis. The effective dates in this Update are the same as those applicable for ASU 2019-10. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to simplify the accounting for income taxes, change the accounting for certain tax transactions, and make minor improvements to the codification. This Update provides a policy election to not allocate consolidated income taxes when a member of a consolidated tax return is not subject to income tax and provides guidance to evaluate whether a step-up in tax basis of goodwill relates to a business combination in which book goodwill was recognized or was a separate transaction. The Update also changes current guidance for making an intraperiod allocation if there is a loss in continuing operations and gains outside of continuing operations, determining when a deferred tax liability is recognized after an investor in a foreign entity transitions to or from the equity method of accounting, accounting for tax law changes and year-to-date losses in interim periods, and determining how to apply the income tax guidance to franchise taxes that are partially based on income. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2020, the FASB issued ASU 2020-1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting, for the purposes of applying the measurement alternative, in accordance with Topic 321, immediately before applying or upon discontinuing the equity method. The amendments also clarify that, for the purpose of applying paragraph 815-10-15-141 (a), an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option, in accordance with the financial instruments guidance in Topic 825. An entity also would evaluate the remaining characteristics in paragraph 815-10-15-141 to determine the accounting for those forward contracts and purchased options. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2020, the FASB issued ASU 2020-2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments – Credit Losses (Topic 326) and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), February 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to add and amend SEC paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Staff Accounting Bulletin No. 119, related to the new credit losses standard, and comments by the SEC staff related to the revised effective date of the new leases standard. This ASU is effective upon issuance. This did not have a significant impact on the Company’s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2020, the FASB issued ASU 2020-3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements to Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This ASU was issued to improve and clarify various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven issues that describe the areas of improvement and the related amendments to GAAP; they are intended to make the standards easier to understand and apply and to eliminate inconsistencies, and they are narrow in scope and are not expected to significantly change practice for most entities. Among its provisions, the ASU clarifies that all entities, other than public business entities that elected the fair value option, are required to provide certain fair value disclosures under ASC 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, in both interim and annual financial statements. It also clarifies that the contractual term of a net investment in a lease under Topic 842 should be the contractual term used to measure expected credit losses under Topic 326. Amendments related to ASU 2019-04 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is not permitted before an entity’s adoption of ASU 2016-01. Amendments related to ASU 2016-13 for entities that have not yet adopted that guidance are effective upon adoption of the amendments in ASU 2016-13. Early adoption is not permitted before an entity’s adoption of ASU 2016-13. Amendments related to ASU 2016-13 for entities that have adopted that guidance are effective for fiscal years beginning after December 15, 2019, including </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">interim periods within those years. Other amendments are effective upon issuance of this ASU. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2020, the FASB issued ASU 2020-4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls reference rate reform, if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform, if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. The amendments in this ASU are effective for all entities upon issuance through December 31, 2022. It is too early to predict whether a new rate index replacement and the adoption of the ASU will have a material impact on the Company’s financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This ASU removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature and (2) convertible instruments with a beneficial conversion feature. As a result, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. This ASU requires entities to provide expanded disclosures about the terms and features of convertible instruments, how the instruments have been reported in the entity’s financial statements, and information about events, conditions, and circumstances that can affect how to assess the amount or timing of an entity’s future cash flows related to those instruments. The amendments in this ASU are effective for public business entities that are not smaller reporting companies, for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. For all other entities, this ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements.</span></div>
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	864300	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.20
CY2020Q3	pwod	Share Price Average Price SharePriceAveragePrice	20.84
	pwod	Share Price Average Price SharePriceAveragePrice	24.20
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	635550	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.30
	pwod	Share Price Average Price SharePriceAveragePrice	28.44
CY2019Q3	pwod	Share Price Average Price SharePriceAveragePrice	28.44
CY2020Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7525561	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7517280	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7522803	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7516406	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	480225	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	480225	shares
	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	480225	shares
	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	480225	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7045336	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7037055	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7042578	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7036181	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7045336	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7037055	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7042578	shares
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	44000	USD
CY2020Q3	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	0	USD
CY2019Q3	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	0	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7036181	shares
CY2020Q3	pwod	Available For Sale Securities In Unrealized Loss Positions Number Of Positions Less Than Twelve Months AvailableForSaleSecuritiesInUnrealizedLossPositionsNumberOfPositionsLessThanTwelveMonths	18	security
CY2020Q3	pwod	Available For Sale Securities In Unrealized Loss Positions Number Of Positions Greater Than Twelve Months AvailableForSaleSecuritiesInUnrealizedLossPositionsNumberOfPositionsGreaterThanTwelveMonths	4	security
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	10744000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	10812000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	66984000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	68131000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	56013000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	60132000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10314000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	10600000	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	144055000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	149675000	USD
CY2020Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	32089000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	37252000	USD
CY2019Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	8157000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	16289000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	1013000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	190000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	1220000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	208000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	1000	USD
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	8000	USD
	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020Q3	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2019Q3	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	124542000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Restricted DebtSecuritiesAvailableForSaleRestricted	74163000	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1291000	USD
CY2019Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1261000	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	USD
CY2019Q3	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-21000	USD
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	30000	USD
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	44000	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
CY2019Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	USD
CY2019Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-21000	USD
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	30000	USD
	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	0	USD
	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	8000	USD
CY2020Q3	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	-2000	USD
CY2019Q3	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	2000	USD
	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	-16000	USD
	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	7000	USD
CY2020Q3	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-2000	USD
CY2019Q3	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	2000	USD
	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	-16000	USD
	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	15000	USD
CY2020Q3	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1333509000	USD
CY2020Q3	pwod	Financing Receivable Recorded Investment30 To89 Days Past Due FinancingReceivableRecordedInvestment30To89DaysPastDue	4002000	USD
CY2020Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	791000	USD
CY2020Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	9762000	USD
CY2020Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1348064000	USD
CY2020Q3	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1076000	USD
CY2020Q3	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1076000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13429000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13429000	USD
CY2020Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1321156000	USD
CY2020Q3	us-gaap	Notes Receivable Net NotesReceivableNet	1335711000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1334612000	USD
CY2019Q4	pwod	Financing Receivable Recorded Investment30 To89 Days Past Due FinancingReceivableRecordedInvestment30To89DaysPastDue	7324000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	2047000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	10374000	USD
CY2019Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1354357000	USD
CY2019Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1187000	USD
CY2019Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1187000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11894000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11894000	USD
CY2019Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1323905000	USD
	pwod	Financing Receivable Individually Evaluated For Impairment On Case By Case Basis Maximum Amount FinancingReceivableIndividuallyEvaluatedForImpairmentOnCaseByCaseBasisMaximumAmount	100000	USD
	pwod	Payment Delays Limit Up To Which Loans Not Classified As Impaired Maximum PaymentDelaysLimitUpToWhichLoansNotClassifiedAsImpairedMaximum	P90D
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1343650000	USD
CY2020Q3	pwod	Loans And Leases Receivable Interest Income If Recorded On Original Loan Basis For Non Accrual Loans LoansAndLeasesReceivableInterestIncomeIfRecordedOnOriginalLoanBasisForNonAccrualLoans	68000	USD
CY2020Q3	pwod	Loans And Leases Receivable Interest On Non Accrual Loans LoansAndLeasesReceivableInterestOnNonAccrualLoans	16000	USD
CY2019Q3	pwod	Loans And Leases Receivable Interest Income If Recorded On Original Loan Basis For Non Accrual Loans LoansAndLeasesReceivableInterestIncomeIfRecordedOnOriginalLoanBasisForNonAccrualLoans	197000	USD
CY2019Q3	pwod	Loans And Leases Receivable Interest On Non Accrual Loans LoansAndLeasesReceivableInterestOnNonAccrualLoans	157000	USD
	pwod	Loans And Leases Receivable Interest Income If Recorded On Original Loan Basis For Non Accrual Loans LoansAndLeasesReceivableInterestIncomeIfRecordedOnOriginalLoanBasisForNonAccrualLoans	186000	USD
	pwod	Loans And Leases Receivable Interest On Non Accrual Loans LoansAndLeasesReceivableInterestOnNonAccrualLoans	19000	USD
	pwod	Loans And Leases Receivable Interest Income If Recorded On Original Loan Basis For Non Accrual Loans LoansAndLeasesReceivableInterestIncomeIfRecordedOnOriginalLoanBasisForNonAccrualLoans	491000	USD
	pwod	Loans And Leases Receivable Interest On Non Accrual Loans LoansAndLeasesReceivableInterestOnNonAccrualLoans	360000	USD
	pwod	Financing Receivable Individually Evaluated For Impairment Minimum Amount FinancingReceivableIndividuallyEvaluatedForImpairmentMinimumAmount	100000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	10298000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	13085000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	4379000	USD
CY2019Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	2059000	USD
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	5	contract
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	4379000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1107000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	14677000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	17464000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1107000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	12393000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	15180000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	4854000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	4936000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1393000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	17247000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	20116000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1393000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	13448000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	168000	USD
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	8935000	USD
CY2020Q3	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	16000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	19391000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	57000	USD
CY2019Q3	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	157000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	15136000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	331000	USD
	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	19000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	20034000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	175000	USD
	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	350000	USD
	pwod	Reasonable Period To Classify From Troubled Debt Restructuring Non Performing Loans To Performing Loans ReasonablePeriodToClassifyFromTroubledDebtRestructuringNonPerformingLoansToPerformingLoans	P6M
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	contract
CY2020Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	contract
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	5	contract
CY2019Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	1	contract
CY2019Q3	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	2059000	USD
CY2019Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	32000	USD
CY2020Q3	pwod	Number Of Categories Considered Not Criticized And Rated NumberOfCategoriesConsideredNotCriticizedAndRated	6	category
CY2020Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1348064000	USD
	pwod	Period Financing Receivables Past Due After Which Loans Are Considered Substandard Minimum PeriodFinancingReceivablesPastDueAfterWhichLoansAreConsideredSubstandardMinimum	P90D
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	8935000	USD
	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	2	contract
CY2020Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	12218000	USD
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	13282000	USD
CY2020Q3	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	376000	USD
CY2019Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	493000	USD
CY2020Q3	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	446000	USD
CY2019Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1354357000	USD
CY2020Q3	pwod	Number Of Components Represent Allowance For Loan Losses NumberOfComponentsRepresentAllowanceForLoanLosses	2	component
CY2020Q3	pwod	Number Of Classes That Groups Loans Are Collectively Evaluated For Impairment NumberOfClassesThatGroupsLoansAreCollectivelyEvaluatedForImpairment	2	class
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12977000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	239000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	46000	USD
CY2020Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	645000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13429000	USD
CY2019Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14001000	USD
CY2019Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	221000	USD
CY2019Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	109000	USD
CY2019Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	360000	USD
CY2019Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14249000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11894000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	700000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	195000	USD
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2040000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13429000	USD
CY2018Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13837000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	888000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	265000	USD
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1035000	USD
CY2019Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14249000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1107000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12322000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13429000	USD
CY2020Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	14677000	USD
CY2020Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1333387000	USD
CY2020Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1348064000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1393000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	10501000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11894000	USD
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	17247000	USD
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1337110000	USD
CY2019Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	1354357000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	161000	USD
CY2019Q3	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	191000	USD
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	481000	USD
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	573000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	330000	USD
CY2019Q3	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	248000	USD
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	956000	USD
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	746000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-52000	USD
CY2019Q3	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-46000	USD
	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-144000	USD
	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-140000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-117000	USD
CY2019Q3	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-11000	USD
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-331000	USD
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-33000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	500000	USD
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1250000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Remainder Of Fiscal Year DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear	250000	USD
CY2020Q3	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	208237000	USD
CY2019Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	204242000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	625800	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	238500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.34
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	238500	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	58125	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	22875	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	35250	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28.02
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	625800	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.29
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	395550	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.08
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	238500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.34
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	240000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28.01
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	864300	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.20
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	635550	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.30
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	97875	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	28.95
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	0	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5307000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5456000	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5534000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5587000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	50000	USD
CY2019Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	65000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	150000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	194000	USD
CY2020Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	53000	USD
CY2019Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	56000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	159000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	168000	USD
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	76000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	99000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	243000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	271000	USD
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	1000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	3000	USD
CY2020Q3	us-gaap	Lease Cost LeaseCost	179000	USD
CY2019Q3	us-gaap	Lease Cost LeaseCost	221000	USD
	us-gaap	Lease Cost LeaseCost	552000	USD
	us-gaap	Lease Cost LeaseCost	636000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	71000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	70000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	291000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	282000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	298000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	283000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	273000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	284000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	263000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	290000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3176000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	8004000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4372000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	9213000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1153000	USD
CY2020Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3679000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3219000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	5534000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P18Y4M24D
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P27Y4M24D
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0351
CY2020Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0377
	pwod	Reclassification Adjustment Effect On Net Income Loss ReclassificationAdjustmentEffectOnNetIncomeLoss	0	USD

Files In Submission

Name	View Source	Status
0000716605-20-000034-index-headers.html	Edgar Link	pending
0000716605-20-000034-index.html	Edgar Link	pending
0000716605-20-000034.txt	Edgar Link	pending
0000716605-20-000034-xbrl.zip	Edgar Link	pending
ex311-2q201.htm	Edgar Link	pending
ex312-2q201.htm	Edgar Link	pending
ex321-2q201.htm	Edgar Link	pending
ex322-2q201.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pwod-20200930.htm	Edgar Link	pending
pwod-20200930.xsd	Edgar Link	pending
pwod-20200930_cal.xml	Edgar Link	unprocessable
pwod-20200930_def.xml	Edgar Link	unprocessable
pwod-20200930_htm.xml	Edgar Link	completed
pwod-20200930_lab.xml	Edgar Link	unprocessable
pwod-20200930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PWOD
PENNS WOODS BANCORP INC Stock $pwod

2020 Q4 Form 10-Q Financial Statement

#000071660520000034 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PWOD PENNS WOODS BANCORP INC Stock $pwod

2020 Q4 Form 10-Q Financial Statement

#000071660520000034 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PWOD
PENNS WOODS BANCORP INC Stock $pwod